|
1
|
Li L, Choi JY, Lee KM, Sung H, Park SK,
Oze I, Pan KF, You WC, Chen YX, Fang JY, et al: DNA methylation in
peripheral blood: A potential biomarker for cancer molecular
epidemiology. J Epidemiol. 22:384–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kitkumthorn N, Tuangsintanakul T,
Rattanatanyong P, Tiwawech D and Mutirangura A: LINE-1 methylation
in the peripheral blood mononuclear cells of cancer patients. Clin
Chim Acta. 413:869–874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Puttipanyalears C, Kitkumthorn N,
Buranapraditkun S, Keelawat S and Mutirangura A: Breast cancer
upregulating genes in stromal cells by LINE-1 hypermethylation and
micrometastatic detection. Epigenomics. 8:475–486. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cooper GM and Hausman RE: The development
and causes of cancer. The cell: A molecular approach (2nd).
725–766. 2000.
|
|
5
|
Shussman N and Wexner SD: Colorectal
polyps and polyposis syndromes. Gastroenterol Rep (Oxf). 2:1–15.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bujanda L, Cosme A, Gil I and
Arenas-Mirave JI: Malignant colorectal polyps. World J
Gastroenterol. 16:3103–3111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Levin B, Lieberman DA, McFarland B,
Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S,
Johnson D, et al: Screening and surveillance for the early
detection of colorectal cancer and adenomatous polyps, 2008: A
joint guideline from the American Cancer Society, the US
Multi-Society Task Force on colorectal cancer, and the American
College of Radiology. Gastroenterology. 134:1570–1595. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ramsey SD, Burke W, Pinsky L, Clarke L,
Newcomb P and Khoury MJ: Family history assessment to detect
increased risk for colorectal cancer: Conceptual considerations and
a preliminary economic analysis. Cancer Epidemiol Biomarkers Prev.
14:2494–2500. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simon K: Colorectal cancer development and
advances in screening. Clin Interv Aging. 11:967–76. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aporntewan C and Mutirangura A: Connection
up-and down-regulation expression analysis of microarrays
(CU-DREAM): A physiogenomic discovery tool. Asian Biomed.
5:257–262. 2011. View Article : Google Scholar
|
|
12
|
Mallone R, Mannering SI, Brooks-Worrell
BM, Durinovic-Belló I, Cilio CM, Wong FS and Schloot NC: Isolation
and preservation of peripheral blood mononuclear cells for analysis
of islet antigen-reactive T cell responses: Position statement of
the T-Cell Workshop Committee of the Immunology of Diabetes
Society. Clin Exp Immunol. 163:33–49. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stathopoulos GP and Armakolas A:
Differences in gene expression between individuals with multiple
primary and single primary malignancies. Int J Mol Med. 24:613–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Galamb O, Sipos F, Solymosi N, Spisak S,
Krenacs T, Toth K, Tulassay Z and Molnar B: Diagnostic mRNA
expression patterns of inflamed, benign, and malignant colorectal
biopsy specimen and their correlation with peripheral blood
results. Cancer Epidemiol Biomarkers Prev. 17:2835–2845. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Angsuwatcharakon P, Rerknimitr R, Kongkam
P, Ridtitid W, Ponauthai Y, Srisuttee R, Kitkumthorn N and
Mutirangura A: Identification of pancreatic cancer in biliary
obstruction patients by FRY site-specific methylation. Asian Pac J
Cancer Prev. 17:4487–4490. 2016.PubMed/NCBI
|
|
16
|
Pixberg C, Raba K, Müller F, Behrens B,
Honisch E, Niederacher D, Neubauer H, Fehm T, Goering W, Schulz W,
et al: Analysis of DNA methylation in single circulating tumor
cells. Oncogene. 36:3223–3231. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krzystek-Korpacka M, Diakowska D,
Kapturkiewicz B, Bębenek M and Gamian A: Profiles of circulating
inflammatory cytokines in colorectal cancer (CRC), high cancer risk
conditions, and health are distinct. Possible implications for CRC
screening and surveillance. Cancer Lett. 337:107–114. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bhome R, Del Vecchio F, Lee GH, Bullock
MD, Primrose JN, Sayan AE and Mirnezami AH: Exosomal microRNAs
(exomiRs): Small molecules with a big role in cancer. Cancer Lett.
420:228–235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schwarzenbach H, Hoon DS and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Villarreal L, Méndez O, Salvans C, Gregori
J, Baselga J and Villanueva J: Unconventional secretion is a major
contributor of cancer cell line secretomes. Mol Cell Proteomics.
12:1046–1060. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ball MP, Li JB, Gao Y, Lee JH, LeProust
EM, Park IH, Xie B, Daley GQ and Church GM: Targeted and
genome-scale strategies reveal gene-body methylation signatures in
human cells. Nat Biotechnol. 27:361–368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aporntewan C, Phokaew C, Piriyapongsa J,
Ngamphiw C, Ittiwut C, Tongsima S and Mutirangura A:
Hypomethylation of intragenic LINE-1 represses transcription in
cancer cells through AGO2. PLoS One. 6:e179342011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
23. Kitkumthorn N and Mutirangura A: Long
interspersed nuclear element-1 hypomethylation in cancer: Biology
and clinical applications. Clin Epigenetics. 2:315–330. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Banville D, Stocco R and Shen SH: Human
protein tyrosine phosphatase 1C (PTPN6) gene structure: Alternate
promoter usage and exon skipping generate multiple transcripts.
Genomics. 27:165–173. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vinayanuwattikun C, Sriuranpong V,
Tanasanvimon S, Chantranuwat P and Mutirangura A:
Epithelial-specific methylation marker: A potential plasma
biomarker in advanced non-small cell lung cancer. J Thorac Oncol.
6:1818–1825. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Afik R, Zigmond E, Vugman M, Klepfish M,
Shimshoni E, Pasmanik-Chor M, Shenoy A, Bassat E, Halpern Z, Geiger
T, et al: Tumor macrophages are pivotal constructors of tumor
collagenous matrix. J Exp Med. 213:2315–2331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xiong GF and Xu R: Function of cancer
cell-derived extracellular matrix in tumor progression. J Cancer
Metastasis Treat. 2:357–364. 2016. View Article : Google Scholar
|
|
28
|
Said AH, Raufman JP and Xie G: The role of
matrix metalloproteinases in colorectal cancer. Cancers (Basel).
6:366–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Illemann M, Bird N, Majeed A, Sehested M,
Laerum OD, Lund LR, Danø K and Nielsen BS: MMP-9 is differentially
expressed in primary human colorectal adenocarcinomas and their
metastases. Mol Cancer Res. 4:293–302. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Georgescu EF, Mogoantă S, Costache A,
Pârvănescu V, Totolici BD, Pătraşcu Ş and Stănescu C: The
assessment of matrix metalloproteinase-9 expression and
angiogenesis in colorectal cancer. Rom J Morphol Embryol.
56:1137–1144. 2015.PubMed/NCBI
|
|
31
|
Herszenyi L, Hritz I, Lakatos G, Varga MZ
and Tulassay Z: The behavior of matrix metalloproteinases and their
inhibitors in colorectal cancer. Int J Mol Sci. 13:13240–13263.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shuman Moss LA, Jensen-Taubman S and
Stetler-Stevenson WG: Matrix metalloproteinases: Changing roles in
tumor progression and metastasis. Am J Pathol. 181:1895–1899. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luczak MW and Jagodziński PP: The role of
DNA methylation in cancer development. Folia Histochem Cytobiol.
44:143–154. 2006.PubMed/NCBI
|
|
34
|
Rasmussen SL, Krarup HB, Sunesen KG,
Johansen MB, Stender MT, Pedersen IS, Madsen PH and
Thorlacius-Ussing O: Hypermethylated DNA, a circulating biomarker
for colorectal cancer detection. PLoS One. 12:e01808092017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Warren JD, Xiong W, Bunker AM, Vaughn CP,
Furtado LV, Roberts WL, Fang JC, Samowitz WS and Heichman KA:
Septin 9 methylated DNA is a sensitive and specific blood test for
colorectal cancer. BMC Med. 9:1332011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Church TR, Wandell M, Lofton-Day C, Mongin
SJ, Burger M, Payne SR, Castaños-Vélez E, Blumenstein BA, Rösch T,
Osborn N, et al: Prospective evaluation of methylated SEPT9 in
plasma for detection of asymptomatic colorectal cancer. Gut.
63:317–325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Danese E and Montagnana M: Epigenetics of
colorectal cancer: Emerging circulating diagnostic and prognostic
biomarkers. Ann Transl Med. 5:2792017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wright M, Beaty JS and Ternent CA:
Molecular Markers for Colorectal Cancer. Surg Clin North Am.
97:683–701. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang JY, Hsieh JS, Chang MY, Huang TJ,
Chen FM, Cheng TL, Alexandersen K, Huang YS, Tzou WS and Lin SR:
Molecular detection of APC, K-ras, and p53 mutations in the serum
of colorectal cancer patients as circulating biomarkers. World J
Surg. 28:721–726. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tutton MG, George ML, Eccles SA, Burton S,
Swift RI and Abulafi AM: Use of plasma MMP-2 and MMP-9 levels as a
surrogate for tumour expression in colorectal cancer patients. Int
J Cancer. 107:541–50. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Holten-Andersen MN, Christensen IJ,
Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, Sørensen S,
Overgaard J, Lilja H, Harris A, et al: Total levels of tissue
inhibitor of metalloproteinases 1 in plasma yield high diagnostic
sensitivity and specificity in patients with colon cancer. Clin
Cancer Res. 8:156–164. 2002.PubMed/NCBI
|
